MY103769A - Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients - Google Patents

Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients

Info

Publication number
MY103769A
MY103769A MYPI88001027A MYPI19881027A MY103769A MY 103769 A MY103769 A MY 103769A MY PI88001027 A MYPI88001027 A MY PI88001027A MY PI19881027 A MYPI19881027 A MY PI19881027A MY 103769 A MY103769 A MY 103769A
Authority
MY
Malaysia
Prior art keywords
water soluble
active compounds
pharmacologically active
solubilisers
pharmaceutical excipients
Prior art date
Application number
MYPI88001027A
Inventor
Hahn Lorenz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY103769A publication Critical patent/MY103769A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A COMBINATION OF A PHARMACOLOGICALLY ACTIVE COMPOUND AND A WATER SOLUBLE MONOESTER OF A SATURATED OR UNSATURATED (C6-18) FATTY ACID AND POLYOL, ESPECIALLY A SACCHARIDE, PARTICULARLY AS A SOLID SOLUTION OF THE ACTIVE COMPOUND IN THE MONOESTER. THE SOLID SOLUTION IS ESPECIALLY SUITABLE FOR SUBSTANTIALLY WATER INSOLUBLE ACTIVE COMPOUNDS, PARTICULARLY SUCH POLYPEPTIDES, E.G. CICLOSPORINS AND IS IN ALL DESIRABLE WEIGHT RATIOS MISCIBLE WITH WATER.
MYPI88001027A 1987-09-15 1988-09-14 Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients MY103769A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3730909 1987-09-15
DE3802355 1988-01-27

Publications (1)

Publication Number Publication Date
MY103769A true MY103769A (en) 1993-09-30

Family

ID=25859774

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI88001027A MY103769A (en) 1987-09-15 1988-09-14 Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients

Country Status (24)

Country Link
JP (1) JP3090666B2 (en)
KR (1) KR0131084B1 (en)
AT (1) AT395819B (en)
AU (1) AU628787B2 (en)
BE (1) BE1001204A5 (en)
CA (1) CA1338775C (en)
CH (1) CH683672A5 (en)
DK (1) DK175132B1 (en)
ES (1) ES2012118A6 (en)
FI (1) FI94837C (en)
FR (1) FR2620336B1 (en)
GB (1) GB2209671B (en)
GR (1) GR1002243B (en)
HU (1) HU205010B (en)
IE (1) IE61195B1 (en)
IL (1) IL87746A (en)
IT (1) IT1224886B (en)
LU (1) LU87335A1 (en)
MY (1) MY103769A (en)
NL (1) NL195094C (en)
NO (1) NO179434C (en)
NZ (1) NZ226163A (en)
PT (1) PT88492B (en)
SE (1) SE503279C2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
GR1000466B (en) * 1989-01-28 1992-07-30 Sandoz Ag Preparation method of novel pharmaceutical forms of cyclosporine
CH679277A5 (en) * 1989-02-09 1992-01-31 Sandoz Ag
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
SG45449A1 (en) 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
ES2168271T3 (en) 1992-09-25 2002-06-16 Novartis Ag PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINS.
DE69426408T2 (en) 1993-09-28 2001-07-12 Scherer Gmbh R P Manufacture of soft gelatin capsules
PT789580E (en) 1994-11-03 2002-09-30 Novartis Ag CYCLOSPORINE FORMULATIONS FOR ORAL ADMINISTRATION WITH SIMPLE COMPOSITION AND HIGH BIODISPONIBILITY AND PROCESS FOR ITS PRODUCTION
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
DE19549852B4 (en) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin containing preparations
TW414696B (en) * 1996-07-01 2000-12-11 Mitsubishi Kagaku Foods Kk Anti-bacteria agent
CZ295207B6 (en) 1997-01-30 2005-06-15 Novartis Ag Hard gelatin capsule containing cyclosporin A
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
WO2005037252A1 (en) * 2003-10-14 2005-04-28 Wockhardt Limited Sterile gelling agents
JP5422871B2 (en) * 2006-10-24 2014-02-19 不二製油株式会社 Isoflavones composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE624258A (en) * 1961-10-31
GB1134878A (en) * 1966-05-12 1968-11-27 Suga Kazuo Improvements in and relating to oryzanol solutions and compositions
FR5986M (en) * 1966-11-22 1968-06-21
BE787842A (en) * 1971-08-25 1972-12-18 Sumito Chemical Cy Ltd PROCESS FOR PREPARING AN AQUEOUS SUSPENSION OF STABLE CRYSTALS OF THE NON-BETA TYPE OF HIGHER FATTY ACID ESTERS OF CHLORAMPHENICOL
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
SE445174B (en) * 1978-03-07 1986-06-09 Sandoz Ag PHARMACEUTICAL COMPOSITION CONTAINING A CYCLOSPORIN AND A HEALING SUBSTANCE
JPS57128634A (en) * 1981-02-03 1982-08-10 Eisai Co Ltd Elastase-containing compound increasing absorption
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
JPS61280435A (en) * 1985-04-04 1986-12-11 Kanji Takada Lymph orienting preparation of cyclosporin

Also Published As

Publication number Publication date
NO884052D0 (en) 1988-09-13
BE1001204A5 (en) 1989-08-16
GB8821443D0 (en) 1988-10-12
IE882772L (en) 1989-03-15
JPH01151526A (en) 1989-06-14
IT8848349A0 (en) 1988-09-14
AU628787B2 (en) 1992-09-24
DK511188D0 (en) 1988-09-14
NO884052L (en) 1989-03-16
GR1002243B (en) 1996-04-22
GR880100602A (en) 1989-06-22
SE8803221L (en) 1989-03-16
HUT49494A (en) 1989-10-30
FR2620336B1 (en) 1991-10-25
SE503279C2 (en) 1996-05-13
AU2217288A (en) 1989-04-27
LU87335A1 (en) 1989-04-06
FR2620336A1 (en) 1989-03-17
NZ226163A (en) 1991-08-27
ES2012118A6 (en) 1990-03-01
DK175132B1 (en) 2004-06-14
JP3090666B2 (en) 2000-09-25
AT395819B (en) 1993-03-25
GB2209671B (en) 1991-11-13
HU205010B (en) 1992-03-30
NO179434C (en) 1996-10-09
IL87746A (en) 1992-07-15
NL8802275A (en) 1989-04-03
IL87746A0 (en) 1989-02-28
KR0131084B1 (en) 1998-04-17
GB2209671A (en) 1989-05-24
ATA224988A (en) 1992-08-15
FI94837B (en) 1995-07-31
IT1224886B (en) 1990-10-24
CA1338775C (en) 1996-12-10
PT88492A (en) 1988-10-01
CH683672A5 (en) 1994-04-29
FI884192A (en) 1989-03-16
DK511188A (en) 1989-03-16
PT88492B (en) 1993-03-31
FI884192A0 (en) 1988-09-13
NL195094C (en) 2003-12-17
SE8803221D0 (en) 1988-09-13
KR890004694A (en) 1989-05-09
FI94837C (en) 1995-11-10
IE61195B1 (en) 1994-10-19
NO179434B (en) 1996-07-01

Similar Documents

Publication Publication Date Title
MY103769A (en) Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients
ES2010226A6 (en) Stable granulocyte colony stimulating factor composition
CA2014889A1 (en) Intra-rectal pharmaceutical foam compositions
IE880600L (en) Low toxicity drug-lipid systems
HU896123D0 (en) Pharmaceutical compositions
NZ222741A (en) Pharmaceutical compositions containing an interferon and a purine derivative
AU1691988A (en) Physiologically active agent for agricultural use
WO1979000401A1 (en) Anti-tumor agent
GB2000025A (en) Nitroimidazole formulations
GB2021409A (en) Pharmaceutical composition
CA2182812A1 (en) Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
ES2007040A6 (en) Osmotic dosage form
HUT45841A (en) Herbicidal compositions comprising 3-amino-2-cyano-acrylic acid ester derivatives as active ingredient and process for producing the active ingredient
GB2208798B (en) Anti-cancer agent comprising l-ascorbic acid and o-benzylidene-l-ascorbic acid or deuterated derivative
GB2186571B (en) Imidazol-1-yl-carboxylic acid ester derivatives, processes for preparing the same and fungicidal compositions comprising the derivative as active component
ZA886885B (en) Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients
ES8303915A1 (en) Pharmaceutical composition of phosphonomicin in tablet form.
AU1447388A (en) Cholesteryl-phosphoryl choline as pharmaceutically active substances
IT1226144B (en) Phosphoric di-ester of ursodeoxycholic acid and its derivatives, process for their preparation and therapeutic compositions which contain them as active substances
JPS5679626A (en) Semi-solid medicine
GB8706483D0 (en) Simmultaneous acquisition active rangefinder
ES8707108A1 (en) Hydrophilising of micronised antibiotic particles